International Journal of Clinical Practice

Primary angioplasty in acute myocardial infarction – the preferred option, but time is of the essence
pp. 379-379(1)

When natural is not harmless
pp. 380-380(1)

Barriers to treating depression in primary care
pp. 381-382(2)

Management and outcomes of acute coronary syndrome with minimal myocardial necrosis: analysis of a large prospective registry from a non-interventional centre
pp. 383-390(8)
Authors: Ray, K. K.; Sheridan, P. J.; Bolton, J.; Clayton, T. C.; Veitch, A.; Manivarmane, R.; Al Rifai, A.; Payne, G.; Baig, W.

A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring
pp. 391-398(8)
Authors: Baguet, J-P; Nisse-Durgeat, S.; Mouret, S.; Asmar, R.; Mallion, J-M

Treating the acute stroke patient as an emergency: current practices and future opportunities
pp. 399-407(9)
Authors: Davis, S.; Lees, K.; Donnan, G.

Magnetic resonance imaging in the quantitative assessment of gouty tophi
pp. 408-414(7)
Authors: Schumacher, H. R.; Becker, M. A.; Edwards, N. L.; Palmer, W. E.; MacDonald, P. A.; Palo, W.; Joseph-Ridge, N.

Evidence of tachyphylaxis associated with salmeterol treatment of chronic obstructive pulmonary disease patients
pp. 415-421(7)
Authors: Tsagaraki, V.; Amfilochiou, A.; Markantonis, S. L.

Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes
pp. 422-428(7)
Authors: Mateo, J. F.; Gil-Guillén, V. F.; Mateo, E.; Orozco, D.; Carbayo, J. A.; Merino, J.

Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients
pp. 429-433(5)
Authors: Ersöz, H. Ö.; Ukinc, K.; Köse, M.; Erem, C.; Gunduz, A.; Hacihasanoglu, A. B.; Karti, S. S.

Vetted access to day case hand surgery
pp. 434-436(3)
Authors: Campbell, A. C.; Sinha, S.

What are the barriers faced by general practitioners in treating depression and anxiety in Hong Kong?
pp. 437-441(5)
Authors: Wong, S. Y. S.; Lee, K.; Chan, K.; Lee, A.

FIELDS of dreams, fields of tears: a perspective on the fibrate trials
pp. 442-449(8)
Author: Wierzbicki, A. S.

Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?
pp. 450-456(7)
Authors: Fletcher, M. A.; Laufer, D. S.; McIntosh, E. D. G.; Cimino, C.; Malinoski, F. J.

Macroprolactin: what is it and what is its importance?
pp. 457-461(5)
Authors: Sadideen, H.; Swaminathan, R.

New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma
pp. 462-470(9)
Authors: Sciarra, A.; Cardi, A.; Dattilo, C.; Mariotti, G.; Di Monaco, F.; Di Silverio, F.

Breast reconstruction
pp. 471-474(4)
Authors: Fentiman, I. S.; Hamed, H.

Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension
pp. 475-481(7)
Authors: O'Callaghan, D. S.; Gaine, S. P.

Tolerability and safety of fluvoxamine and other antidepressants
pp. 482-491(10)
Authors: Westenberg, H. G. M.; Sandner, C.

Anticholinergic syndrome due to `Devil's herb': when risks come from the ancient time
pp. 492-494(3)
Authors: Piccillo, G. A.; Miele, L.; Mondati, E.; Moro, P. A.; Musco, A.; Forgione, A.; Gasbarrini, G.; Grieco, A.

Inflammation in atrial fibrillation and atherosclerosis: pearls and pitfalls in the theorising process
pp. 495-496(2)

The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept
pp. 497-498(2)

Do the National Institute of Clinical Excellence guidelines apply to `real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting?
pp. 498-499(2)

Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy
pp. 500-503(4)
Authors: Gorkin, L.; Hvidsten, K.; Sobel, R. E.; Siegel, R.